Safety and efficacy of immune checkpoint inhibitors in patients with pre-treatment reduced left ventricular function

Maor Tzuberi
Rafael Y. Brzezinski
Nir Flint
Moaad Slieman
Lior Zornitzki
Dana Viskin
Anna Rozenfeld Hemed
Barliz Waissengrin
Renana Barak
Inbal Golomb
Ido Wolf
Netanel Golan
Yan Topilsky
Shmuel Banai
Livia Kapusta
Michal Laufer-Perl

Read the full article

Listed in

This article is not in any list yet, why not save it to one of your lists.

Log in to save this article

Abstract

No abstract available

Version published to 10.1186/s40959-024-00297-z
Jan 8, 2025
Version published to 10.21203/rs.3.rs-5171357/v1 on Research Square
Dec 9, 2024

Cardiotoxicity Monitoring and Cancer Therapy-Related Cardiac Dysfunction in a Heterogeneous Cancer Population: A Retrospective Study

This article has 8 authors:
1. Madeline Stevenson
2. Sihyeong Park
3. Taylor Hartshorne
4. Zachary Mendoza
5. Vinh Nguyen
6. Lucas Wong
7. Christopher Chiles
8. R. Jay Widmer
This article has no evaluationsLatest version Dec 18, 2024
Analysis of the effectiveness and safety of targeted therapy combined with immune checkpoint inhibitors and systemic chemotherapy in the first-line treatment of advanced biliary malignancies

This article has 6 authors:
1. Lu Zhao
2. Zhengfeng Zhang
3. Dazhen Wang
4. Liu Yang
5. Ze Liu
6. Changjie Lou
This article has no evaluationsLatest version Dec 16, 2024
Prognostic value of systemic immune-inflammation index in patients with small-cell lung cancer treated with immune checkpoint inhibitors

This article has 15 authors:
1. Yusuke Hamakawa
2. Ayumi Hirahara
3. Akiko Hayashi
4. Kota Ito
5. Hiroyuki Shinohara
6. Aya Shiba
7. Yuko Higashi
8. Masaharu Aga
9. Kazuhito Miyazaki
10. Yuri Taniguchi
11. Yuki Misumi
12. Yoko Agemi
13. Yukiko Nakamura
14. Tsuneo Shimokawa
15. Hiroaki Okamoto
This article has no evaluationsLatest version Jan 6, 2025